Evidence map›Paper›PMID 32948930›Full record

ArticleMolecular neurobiology2021

Differential Regional Responses in Soluble Monomeric Alpha Synuclein Abundance Following Traumatic Brain Injury.

S W Carlson, H Q Yan, Y Li, J Henchir, X Ma, M S Young, M D Ikonomovic, C E Dixon

Open access · greenAbstract read
In one paragraph

Article in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. The Role of α-Synuclein in Etiology of Neurodegenerative Diseases.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

S W CarlsonNeurological Surgery, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA.ORCID https://orcid.org/0000-0002-1413-5075
H Q YanNeurological Surgery, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA.
Y LiNeurological Surgery, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA.
J HenchirNeurological Surgery, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA.
X MaNeurological Surgery, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA.
M S YoungNeurological Surgery, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA.
M D IkonomovicNeurology, University of Pittsburgh, 200 Lothrop Street, Pittsburgh, PA, 15261, USA.ORCID https://orcid.org/0000-0002-8745-3293
C E DixonNeurological Surgery, University of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA. dixonec@upmc.edu.ORCID https://orcid.org/0000-0002-8075-0025
University of Pittsburgh · USUPMC Health System · US

Funding

Alpha-Synuclein and Synaptic Vesicle Dysfunction after Traumatic Brain InjuryR01NS091062 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DIXON, C EDWARD · 2015 to 2019
$1.7M
SNARE Proteins and TBIR01NS079061 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DIXON, C EDWARD · 2012 to 2016
$1.6M
SV2A as a Therapeutic Target for Improved Neurotransmission after Traumatic Brain InjuryR21NS111099 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CARLSON, SHAUN · 2019 to 2020
$430k
Lithium as a Therapeutic Approach to Attenuate Synaptic Deficits after TBIF32NS090748 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CARLSON, SHAUN · 2015 to 2016
$112k
Chronic Lithium Therapy for Traumatic Brain InjuryI01RX001127 · VA · VETERANS HEALTH ADMINISTRATION · PI DIXON, C EDWARD · 2014 to 2018
–
Multifunctional rehabilitative therapy to reduce Alzheimer pathology after TBII01RX001778 · VA · VETERANS HEALTH ADMINISTRATION · PI DIXON, C EDWARD, IKONOMOVIC, MILOS D · 2016 to 2020
–
National Institutes of Health (US) NS079061National Institutes of Health (US) NS091062National Institutes of Health (US) NS111099NINDS NIH HHS F32 NS090748NINDS NIH HHS R01 NS079061NINDS NIH HHS R01 NS091062NINDS NIH HHS R21 NS111099RRD VA I01 RX001127RRD VA I01 RX001778U.S. Department of Veterans Affairs (US) VAI01RX001778
6 · The paper itself

Abstract

Alpha synuclein (α-synuclein) is a neuronal protein found predominately in presynaptic terminals. While the pathological effect of α-synuclein aggregates has been a topic of intense study in several neurodegenerative conditions, less attention has been placed on changes in monomeric α-synuclein and related physiological consequences on neuronal function. A growing body of evidence supports an important physiological role of α-synuclein in neurotransmission. In the context of traumatic brain injury (TBI), we hypothesized that the regional abundance of soluble monomeric α-synuclein is altered over a chronic time period post-injury. To this end, we evaluated α-synuclein in the cortex, hippocampus, and striatum of adult rats at 6 h, 1 day, 1, 2, 4, and 8 weeks after controlled cortical impact (CCI) injury. Western blot analysis demonstrated decreased levels of monomer α-synuclein protein in the ipsilateral hippocampus at 6 h, 1 day, 1, 2, and 8 weeks, as well as in the ipsilateral cortex at 1 and 2 weeks and in the ipsilateral striatum at 6 h after CCI compared with sham animals. Immunohistochemical analysis revealed lower α-synuclein and a modest reduction in synaptophysin staining in the ipsilateral hippocampus at 1 week after CCI compared with sham animals, with no evidence of intracellular or extracellular α-synuclein aggregates. Collectively, these findings demonstrate that monomeric α-synuclein protein abundance in the hippocampus is reduced over an extensive (acute-to-chronic) post-injury interval. This deficit may contribute to the chronically impaired neurotransmission known to occur after TBI.

Indexed as

alpha-SynucleinAnimalsBrainBrain Injuries, TraumaticMaleNeuraminidaseRatsRats, Sprague-DawleySolubilitySynaptophysinalpha-SynucleinNeuraminidaseSynaptophysinNeurodegenerationSynapseTraumatic brain injuryα-synuclein

Identifiers

PMID32948930
PMCPMC7704579
OpenAlexW3087520692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.